WallStreetZenWallStreetZen

NASDAQ: KOD
Kodiak Sciences Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for KOD

Based on 3 analysts offering 12 month price targets for Kodiak Sciences Inc

Min Forecast
$14.00-68.26%
Avg Forecast
$50.67+14.87%
Max Forecast
$80.00+81.36%

Should I buy or sell KOD stock?

Based on 3 analysts offering ratings for Kodiak Sciences Inc.

Buy
Strong Buy
1 analysts 33.33%
Buy
1 analysts 33.33%
Hold
1 analysts 33.33%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although KOD's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates KOD as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their KOD stock forecasts and price targets.

KOD stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-03-27Find Out Why
lockedlocked$00.00+00.00%2026-03-27
lockedlocked$00.00+00.00%2025-11-17

1 of 1

Forecast return on equity

Is KOD forecast to generate an efficient return?

Company
27.19%
Industry
66.25%
Market
172.91%
KOD's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is KOD forecast to generate an efficient return on assets?

Company
12.17%
Industry
30.34%
KOD is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

KOD earnings per share forecast

What is KOD's earnings per share in the next 3 years based on estimates from 7 analysts?

Avg 1 year Forecast
-$3.74
Avg 2 year Forecast
-$3.53
Avg 3 year Forecast
-$1.19

KOD revenue forecast

What is KOD's revenue in the next 3 years based on estimates from 5 analysts?

Avg 1 year Forecast
$0.0
Avg 2 year Forecast
$64.2M
Avg 3 year Forecast
$238.7M

KOD vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
KOD$44.11$50.67+14.87%Buy
SLNO$52.75$61.17+15.96%Hold
VCYT$33.85$43.83+29.49%Buy
ELVN$44.90$50.50+12.47%Buy
RLAY$14.95$18.29+22.31%Strong Buy
View Top Biotech Stocks

Kodiak Sciences Stock Forecast FAQ

Is Kodiak Sciences Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: KOD) stock is to Buy KOD stock.

Out of 3 analysts, 1 (33.33%) are recommending KOD as a Strong Buy, 1 (33.33%) are recommending KOD as a Buy, 1 (33.33%) are recommending KOD as a Hold, 0 (0%) are recommending KOD as a Sell, and 0 (0%) are recommending KOD as a Strong Sell.

If you're new to stock investing, here's how to buy Kodiak Sciences stock.

What is KOD's earnings growth forecast for 2026-2028?

(NASDAQ: KOD) Kodiak Sciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.71%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 35.62%.

Kodiak Sciences's earnings in 2026 is -$229,967,000.On average, 7 Wall Street analysts forecast KOD's earnings for 2026 to be -$231,001,794, with the lowest KOD earnings forecast at -$275,173,543, and the highest KOD earnings forecast at -$146,764,996. On average, 5 Wall Street analysts forecast KOD's earnings for 2027 to be -$218,477,601, with the lowest KOD earnings forecast at -$241,837,541, and the highest KOD earnings forecast at -$192,223,180.

In 2028, KOD is forecast to generate -$73,500,009 in earnings, with the lowest earnings forecast at -$117,585,170 and the highest earnings forecast at -$17,533,871.

What is KOD's revenue growth forecast for 2026-2028?

(NASDAQ: KOD) Kodiak Sciences's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.38%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.35%.

Kodiak Sciences's revenue in 2026 is $0.On average, 5 Wall Street analysts forecast KOD's revenue for 2026 to be $0, with the lowest KOD revenue forecast at $0, and the highest KOD revenue forecast at $0. On average, 5 Wall Street analysts forecast KOD's revenue for 2027 to be $3,972,426,842, with the lowest KOD revenue forecast at $3,013,599,314, and the highest KOD revenue forecast at $4,614,531,429.

In 2028, KOD is forecast to generate $14,761,231,133 in revenue, with the lowest revenue forecast at $11,423,920,068 and the highest revenue forecast at $17,339,668,833.

What is KOD's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: KOD) forecast ROA is 12.17%, which is lower than the forecast US Biotechnology industry average of 30.34%.

What is KOD's Price Target?

According to 3 Wall Street analysts that have issued a 1 year KOD price target, the average KOD price target is $50.67, with the highest KOD stock price forecast at $80.00 and the lowest KOD stock price forecast at $14.00.

On average, Wall Street analysts predict that Kodiak Sciences's share price could reach $50.67 by Mar 27, 2027. The average Kodiak Sciences stock price prediction forecasts a potential upside of 14.87% from the current KOD share price of $44.11.

What is KOD's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: KOD) Kodiak Sciences's current Earnings Per Share (EPS) is -$4.32. On average, analysts forecast that KOD's EPS will be -$3.74 for 2026, with the lowest EPS forecast at -$4.45, and the highest EPS forecast at -$2.37. On average, analysts forecast that KOD's EPS will be -$3.53 for 2027, with the lowest EPS forecast at -$3.91, and the highest EPS forecast at -$3.11. In 2028, KOD's EPS is forecast to hit -$1.19 (min: -$1.90, max: -$0.28).

What is KOD's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: KOD) forecast ROE is 27.19%, which is considered strong.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.